Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.


TSXV:CLAS.H - Post by User

Comment by PowerofNowon Mar 01, 2021 6:13pm
172 Views
Post# 32691245

RE:RE:TARGET SELLS? Added another 260k: Holding 680k shares

RE:RE:TARGET SELLS? Added another 260k: Holding 680k shares True. I changed my mind about .38 cent price point sell to $1 as well. I usually let go of 50% of shares on a ride up towards .50 cents but this stock is a major exception. I was on a long walk this evening and had a vision of it going to $1 days after I would have sold at .38 cents. I never go against my gut when it comes to stock plays and try my best not to be greedy which pays off.
011Peking wrote:

I bought another 100k shares today. 600k total.
I'm not selling anything under 1$. 


My strategy tho is to have my 500k shares in for the long run. Not touching them. And maybe play around a bit with 100k shares just for fun. Trading a bit. 



<< Previous
Bullboard Posts
Next >>